Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04579380
Title Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seagen Inc.
Indications

Advanced Solid Tumor

brain cancer

Her2-receptor negative breast cancer

Therapies

Trastuzumab + Tucatinib

Fulvestrant + Trastuzumab + Tucatinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.